📰 Lantern Pharma News
Lantern Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lantern Pharma. Real-time updates on events, politics, business and more.
May 6, 2024
XCE853 is Oregon Therapeutic’s first-in-class, and potentially best-in-class PDI inhibitor, exhibiting potent preclinical efficacy across multiple solid and hematological cancers, and is ready to...
May 2, 2024
Q1 2024 Earnings Results & Corporate Updates Webcast to be held Thursday, May 9th, 4:30 p.m. ET, register for webcast here, or at the link provided below. ...
April 26, 2024
HC Wainwright reaffirmed their neutral rating on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a research note published on Thursday morning, Benzinga reports. Lantern Pharma Stock Performance Shares of NASDAQ LTRN opened at $5.46 on Thursday. Lantern Pharma has a 12 month low of $2.38 and a 12 month high of $11.99. The […]
April 24, 2024
Webinar Wednesdays is planned to be held on the last Wednesday of each month - starting on Wednesday, April 24th with the first webinar on the increasing prevalence of non-small cell lung cancer in...
April 22, 2024
Global Camps Africa is pleased to announce that Dr. Anthony Fauci, renowned immunologist and public health advocate, was honored with the Sizanani Award at its annual gala event in Washington, DC on April 20th. The Sizanani Award, which translates...
April 22, 2024
Approximately 33% of all non-small cell lung cancer patients in East Asia are never smokers – a growing and unaddressed patient population. Dr. Yashushi Goto a leading lung cancer...
April 22, 2024
22.04.2024 - Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, ... Seite 1
April 10, 2024
/PRNewswire/ -- With the increase in life expectancy, people need more medical help and care. AI-enabled technologies can help people to live healthier and...
April 5, 2024
The precision oncology medicine company guided three drugs in the trial pipeline with uncommon efficiency.
April 5, 2024
By P. Mohan Chandran Who is an inventor? Is it the genius mind behind the innovation or the hand that crafts the creation? Or perhaps it is the advanced